Kerr, David J |
NCT04938388: Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care |
|
|
| Terminated | 4 | 12 | US | Semaglutide Pill, Semaglutide 3 mg, Semaglutide 7 mg, Semaglutide 14 mg, Fresh organic vegetables | Sansum Diabetes Research Institute, Novo Nordisk A/S | Diabetes Mellitus, Type 2, Glucose Metabolism Disorders (Including Diabetes Mellitus) | 02/23 | 02/23 | | |
| Terminated | N/A | 50 | US | Avocado Vouchers | Sansum Diabetes Research Institute, Hass Avocado Board | Dietary Habits, Diabetes Mellitus, Type 2 | 01/23 | 01/23 | | |
NCT05368454: Evaluation of a Digital Diabetes Self-Management Education and Support Program |
|
|
| Completed | N/A | 100 | US | Online Diabetes Self-Management Education and Support (DSMES) Program, Standard of Care | Omada Health, Inc., Abbott Diabetes Care, Evidation Health | Type 2 Diabetes | 01/24 | 01/24 | | |
NCT05000840: Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA |
|
|
| Recruiting | N/A | 750 | US | Enrollment in existing SDRI diabetes education programs | Sansum Diabetes Research Institute, Abbott, DexCom, Inc. | Diabetes Mellitus, Type 2, Cardiovascular Diseases | 07/24 | 12/24 | | |
NCT04991142: Models of Nutrition From Continuous Glucose Monitors |
|
|
| Completed | N/A | 45 | US | | Texas A&M University, Sansum Diabetes Research Institute | Diabetes Mellitus, Type 2, Pre-diabetes, Diet Habit, Diet, Healthy | 08/24 | 08/24 | | |
Hickish, Tamas |
| Recruiting | 2 | 500 | Europe | FOLFOX-A, Gemcitabe and Abraxane, G-CSF | Judith Dixon-Hughes, NHS Greater Glasgow and Clyde, University of Glasgow | Neoplasms Pancreatic | 12/25 | 01/26 | | |
FAIM, NCT04920708: Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression |
|
|
| Recruiting | 2 | 324 | Europe | Ipatasertib 300mg, RG7440, Fulvestrant 500g, Faslodex, Palbociclib 75mg-125mg, Ibrance, CDK4/6 Inhibitor, Abemaciclib / Ribociclib / Palbociclib | Royal Marsden NHS Foundation Trust, Pfizer, Hoffmann-La Roche | Metastatic Breast Cancer, ER+ Breast Cancer, Advanced Breast Cancer | 09/26 | 09/26 | | |
NCT04161417: Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer |
|
|
| Recruiting | N/A | 2500 | Europe | Patients with suspected or confirmed pancreatic cancer will be be asked to provide biopsy material for molecular profiling | Judith Dixon-Hughes, Cancer Research UK, NHS Greater Glasgow and Clyde | Neoplasms Pancreatic | 12/25 | 12/25 | | |
Middleton, Robert |
| Active, not recruiting | N/A | 150 | Europe | MASTER SL femoral stem and DELTA TT acetabular cup | Limacorporate S.p.a | Patients Requiring Hip Replacement | 12/21 | 12/23 | | |
| Not yet recruiting | N/A | 30 | Europe | VO2 max | Bournemouth University, Nuffield Health Bournemouth | Hip Osteoarthritis | 04/26 | 04/26 | | |
NCT04754087: G7 Acetabular System with Vivacit-E or Longevity Liner PMCF Study |
|
|
| Recruiting | N/A | 300 | Europe, US | Vivacit-E and Longevity (HXLPE) Liners | Zimmer Biomet | Total Hip Arthroplasty, Degenerative Joint Disease of Hip, Avascular Necrosis of Hip, Rheumatoid Arthritis of Hip, Osteoarthritis, Hip, Osteoarthritis of Hip, Fractures, Hip, Fracture of Hip | 12/33 | 12/33 | | |
Bent, Clare |
NCT04941924: The ID- RFA Trial: A Trial of Intraductal Radio-frequency Ablation (ID-RFA) Plus Biliary Stenting Versus Biliary Stenting Alone for the Treatment of Malignant Biliary Obstruction. |
|
|
| Recruiting | N/A | 24 | Europe | Intraductal Radio-Frequency Ablation, Biliary Stent Placement | University Hospitals Dorset NHS Foundation Trust, The Christie NHS Foundation Trust | Malignant Biliary Obstruction | 10/23 | 10/23 | | |
Thavanesan, Kamy |
| Active, not recruiting | 4 | 948 | Europe, Canada, US, RoW | Edoxaban, Lixiana, Savaysa, Non-anticoagulant medical therapy | Population Health Research Institute | Intracranial Hemorrhages, Atrial Fibrillation | 04/26 | 10/26 | | |
OPTIMAS, NCT03759938: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial |
|
|
| Active, not recruiting | N/A | 3648 | Europe | Direct oral anticoagulant (DOAC), dabigatran, apixaban, edoxaban, rivaroxaban | University College, London | Stroke, Acute, Atrial Fibrillation | 05/24 | 10/24 | | |
| Recruiting | N/A | 1200 | Europe | geko™ device, geko, NMES | Firstkind Ltd, National Institute for Health Research, United Kingdom, Keele University, University Hospitals of North Midlands NHS Trust, University of California, Bournemouth University | Stroke, Acute, Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism | 04/25 | 06/25 | | |
Azim, Abul |
PROHIBIT-ICH, NCT03863665: Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage |
|
|
| Terminated | N/A | 86 | Europe | A&D BP Digital Blood Pressure Monitor (UA-767PBT-Ci) CE Declaration UA-767PBT-Ci | University College, London, University of Oxford, The Stroke Association, United Kingdom | Intracerebral Hemorrhage | 05/22 | 04/23 | | |
OPTIMAS, NCT03759938: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial |
|
|
| Active, not recruiting | N/A | 3648 | Europe | Direct oral anticoagulant (DOAC), dabigatran, apixaban, edoxaban, rivaroxaban | University College, London | Stroke, Acute, Atrial Fibrillation | 05/24 | 10/24 | | |
| Recruiting | N/A | 1200 | Europe | geko™ device, geko, NMES | Firstkind Ltd, National Institute for Health Research, United Kingdom, Keele University, University Hospitals of North Midlands NHS Trust, University of California, Bournemouth University | Stroke, Acute, Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism | 04/25 | 06/25 | | |
Araque, Paloma Rodríguez |
| Recruiting | 3 | 852 | Europe, Canada, US, RoW | VE303, Placebo | Vedanta Biosciences, Inc. | Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, CDI, C. Diff Infection, Recurrent Clostridium Difficile Infection, C.Difficile Diarrhea, Diarrhea Infectious | 06/27 | 10/27 | | |